688513 苑东生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)7.9148.9888.97710.41010.596
总资产报酬率 ROA (%)6.3277.0627.1208.5118.761
投入资产回报率 ROIC (%)7.3938.2248.2479.94610.283

边际利润分析
销售毛利率 (%)75.69174.92580.01383.25585.990
营业利润率 (%)23.72218.66921.63922.26623.868
息税前利润/营业总收入 (%)23.28917.65320.63221.50723.755
净利润/营业总收入 (%)21.60317.65020.28221.06122.722

收益指标分析
经营活动净收益/利润总额(%)77.84074.37068.39065.41456.310
价值变动净收益/利润总额(%)6.5419.80410.54310.62717.027
营业外收支净额/利润总额(%)0.1380.241-0.0400.5191.120

偿债能力分析
流动比率 (X)3.4983.2342.8483.2284.114
速动比率 (X)3.1192.9162.6052.9623.874
资产负债率 (%)19.47120.65222.21118.99217.425
带息债务/全部投入资本 (%)4.4554.1498.9493.8781.095
股东权益/带息债务 (%)2,096.6322,252.0251,001.0032,435.0878,836.862
股东权益/负债合计 (%)413.597384.207350.236426.547473.874
利息保障倍数 (X)-49.986-16.641-20.659-24.583-62.008

营运能力分析
应收账款周转天数 (天)52.39339.69341.42938.34841.127
存货周转天数 (天)226.102186.713243.347224.584235.768